TNYA
Tenaya Therapeutics Inc

1,867
Mkt Cap
$234.77M
Volume
357.00
52W High
$3.69
52W Low
$0.36
PE Ratio
-1.78
TNYA Fundamentals
Price
$1.40
Prev Close
$1.41
Open
$1.43
50D MA
$1.52
Beta
2.13
Avg. Volume
2.83M
EPS (Annual)
-$1.31
P/B
2.77
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have received a consensus rating of "Moderate Buy" from the five analysts that are covering the company, Marketbeat Ratings...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have received a consensus rating of "Moderate Buy" from the five analysts that are covering the company, Marketbeat Ratings...
MarketBeat·7d ago
News Placeholder
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have received a consensus rating of "Moderate Buy" from the five analysts that are covering the company, Marketbeat Ratings...
MarketBeat·7d ago
News Placeholder
Chardan Capital Issues Optimistic Forecast for TNYA Earnings
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Free Report) - Equities researchers at Chardan Capital boosted their FY2025 EPS estimates for shares of Tenaya Therapeutics in a research note issued to...
MarketBeat·26d ago
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Releases Quarterly Earnings Results
Tenaya Therapeutics (NASDAQ:TNYA - Get Free Report) posted its earnings results on Monday. The company reported ($0.12) earnings per share for the quarter, topping analysts' consensus estimates of...
MarketBeat·29d ago
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Receives Buy Rating from Chardan Capital
Chardan Capital restated a "buy" rating and issued a $9.00 target price on shares of Tenaya Therapeutics in a research note on Monday...
MarketBeat·30d ago
News Placeholder
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) have received a consensus rating of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat.com...
MarketBeat·1mo ago
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Stock Price Down 2.2% - Time to Sell?
Tenaya Therapeutics (NASDAQ:TNYA) Trading Down 2.2% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.
Stocktwits·9mo ago

Latest TNYA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.